A Clinical Audit Report on Compliance to Hepatitis B Vaccination in Type 2 Diabetes Mellitus Patients in a Primary Health Care Centre in Qatar

Maxwell Sleiman
{"title":"A Clinical Audit Report on Compliance to Hepatitis B Vaccination in Type 2 Diabetes Mellitus Patients in a Primary Health Care Centre in Qatar","authors":"Maxwell Sleiman","doi":"10.38125/oajbs.000368","DOIUrl":null,"url":null,"abstract":": Numerous infectious diseases can be prevented in adults through a vaccination strategy.” The hepatitis B disease was found to be greater in diabetic patients. Since 2011, the American Advisory Committee on Immunization Practices has recommended that diabetic patients be vaccinated against hepatitis B. Patients with diabetes mellitus are at an increased risk of contracting hepatitis B virus infection and its complications. Aim : The purpose of this study was to determine compliance with the audit criterion for hepatitis B vaccination among diabetic patients and to recommend changes in practice to improve hepatitis B vaccination coverage among type 2 diabetes mellitus patients under the age of 60. Methodology : A random sample of 50 patients with Type 2 Diabetes Mellitus aged less than 60 years who presented to Umm Ghuwailina Health Centre (UMG-HC) during the study period will be evaluated for hepatitis B vaccination records during the audit period, which runs from August 1 st to October 31 st, 2019. Results : Only 8% (6.8% men and 9.5% women) in the audit group had received hepatitis B vaccine. Hepatitis B vaccination coverage was found to be low in patients with diabetes mellitus, indicating their vulnerability to this deadly disease. Conclusion : Hepatitis B vaccination coverage was extremely low among a randomly selected diabetic population in a primary health care centre in Qatar. This may increase the risk of infection with hepatitis B in this population. In patients with diabetes, the hepatitis B vaccine is immunogenic and has a similar safety profile to vaccination in healthy controls. Due to the fact that increasing age is generally associated with a decline in seroprotection rates, the hepatitis B vaccine should be administered as soon as possible following diabetes diagnosis. Much work is required to raise awareness among health care providers and diabetic patients about the importance of hepatitis B vaccination.","PeriodicalId":207626,"journal":{"name":"Open Access Journal of Biomedical Science","volume":"273 18-20","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Access Journal of Biomedical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.38125/oajbs.000368","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

: Numerous infectious diseases can be prevented in adults through a vaccination strategy.” The hepatitis B disease was found to be greater in diabetic patients. Since 2011, the American Advisory Committee on Immunization Practices has recommended that diabetic patients be vaccinated against hepatitis B. Patients with diabetes mellitus are at an increased risk of contracting hepatitis B virus infection and its complications. Aim : The purpose of this study was to determine compliance with the audit criterion for hepatitis B vaccination among diabetic patients and to recommend changes in practice to improve hepatitis B vaccination coverage among type 2 diabetes mellitus patients under the age of 60. Methodology : A random sample of 50 patients with Type 2 Diabetes Mellitus aged less than 60 years who presented to Umm Ghuwailina Health Centre (UMG-HC) during the study period will be evaluated for hepatitis B vaccination records during the audit period, which runs from August 1 st to October 31 st, 2019. Results : Only 8% (6.8% men and 9.5% women) in the audit group had received hepatitis B vaccine. Hepatitis B vaccination coverage was found to be low in patients with diabetes mellitus, indicating their vulnerability to this deadly disease. Conclusion : Hepatitis B vaccination coverage was extremely low among a randomly selected diabetic population in a primary health care centre in Qatar. This may increase the risk of infection with hepatitis B in this population. In patients with diabetes, the hepatitis B vaccine is immunogenic and has a similar safety profile to vaccination in healthy controls. Due to the fact that increasing age is generally associated with a decline in seroprotection rates, the hepatitis B vaccine should be administered as soon as possible following diabetes diagnosis. Much work is required to raise awareness among health care providers and diabetic patients about the importance of hepatitis B vaccination.
卡塔尔一家初级保健中心2型糖尿病患者乙肝疫苗接种依从性的临床审计报告
许多传染病可以通过疫苗接种策略在成人中预防。发现糖尿病患者的乙型肝炎发病率更高。自2011年以来,美国免疫实践咨询委员会建议糖尿病患者接种乙型肝炎疫苗。糖尿病患者感染乙型肝炎病毒及其并发症的风险增加。目的:本研究的目的是确定糖尿病患者乙型肝炎疫苗接种审计标准的依从性,并建议改变实践,以提高60岁以下2型糖尿病患者的乙型肝炎疫苗接种覆盖率。方法:在研究期间随机抽取50名年龄在60岁以下的2型糖尿病患者,并在2019年8月1日至10月31日的审计期间对其进行乙型肝炎疫苗接种记录评估。结果:审计组中只有8%(男性6.8%,女性9.5%)接种了乙肝疫苗。发现糖尿病患者的乙肝疫苗接种率较低,表明他们易患这种致命疾病。结论:在卡塔尔的一个初级卫生保健中心随机选择的糖尿病人群中,乙肝疫苗接种覆盖率极低。这可能会增加这一人群感染乙型肝炎的风险。在糖尿病患者中,乙肝疫苗具有免疫原性,其安全性与健康对照组相似。由于年龄的增长通常与血清保护率的下降有关,因此在诊断出糖尿病后应尽快接种乙型肝炎疫苗。要提高卫生保健提供者和糖尿病患者对乙肝疫苗接种重要性的认识,还需要做很多工作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信